HomeTagsHormone Therapy

Hormone Therapy

Off the Wire

Olaparib Study Cites Manageable Side Effects, No Lasting Quality of Life Impact

BCNewswire Staff -
A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...
Features

Decade-Long Triumph: Paclitaxel and Trastuzumab in Small HER2-Positive Breast Cancer

BCNewswire Staff -
Over a notable duration of nearly 11 years, a study just published in The Lancet, confirms that the combination therapy of adjuvant paclitaxel and...
Risk

BCI Test Predicts Breast Cancer Recurrence Risk in Hormone Therapy Patients

BCNewswire Staff -
The Breast Cancer Index (BCI) has been validated as a tool for predicting the risk of breast cancer recurrence in postmenopausal women treated with...
Latest

New Research Shines Light on Hormone Therapy Resistance in Breast Cancer

BCNewswire Staff -
Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment. A...
Off the Wire

Elacestrant Unveiled: A New Horizon for Hormone-Driven Breast Cancer

BCNewswire Staff -
Patients with a type of breast cancer that grows in response to estrogen (ER-positive) but does not have the HER2 protein (HER2-negative) often start...
12Page 1 of 2

Hot Topics

Load more

©BCnewswire. All rights reserved. Information found here is for background research. Consult your doctor for more.

Must Read

Popular Articles